Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Combaret V"'
Autor:
Plantaz, D., Freycon, C., Schiff, I., Durand, C., Combaret, V., Pagnier, A., Piolat, C., Sartelet, H.
Publikováno v:
In EMC – Pediatría March 2023 58(1):1-17
Autor:
Chen, J, Nelson, C, Wong, M, Tee, AE, Liu, PY, La, T, Fletcher, JI, Kamili, A, Mayoh, C, Bartenhagen, C, Trahair, TN, Xu, N, Jayatilleke, N, Peng, H, Atmadibrata, B, Cheung, BB, Lan, Q, Bryan, TM, Mestdagh, P, Vandesompele, J, Combaret, V, Boeva, V, Wang, JY, Janoueix-Lerosey, I, Cowley, MJ, MacKenzie, KL, Dolnikov, A, Li, J, Polly, P, Marshall, GM, Reddel, RR, Norris, MD, Haber, M, Fischer, M, Zhang, XD, Pickett, HA, Liu, T
PurposeTERT gene rearrangement with transcriptional superenhancers leads to TERT overexpression and neuroblastoma. No targeted therapy is available for clinical trials in patients with TERT-rearranged neuroblastoma.Experimental designAnticancer agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::e304684dc45deac0e7292e9fe1f60923
https://hdl.handle.net/10453/148374
https://hdl.handle.net/10453/148374
Autor:
Ambros IM, Tonini GP, Pötschger U, Gross N, Mosseri V, Beiske K, Berbegall AP, Bénard J, Bown N, Caron H, Combaret V, Couturier J, Defferrari R, Delattre O, Jeison M, Kogner P, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Valent A, Van Roy N, Villamon E, Janousek D, Pribill I, Glogova E, Attiyeh EF, Hogarty MD, Monclair TF, Holmes K, Valteau-Couanet D, Castel V, Tweddle DA, Park JR, Cohn S, Ladenstein R, Beck-Popovic M, De Bernardi B, Michon J, Pearson ADJ, Ambros PF
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
For localized, resectable neuroblastoma without MYCN amplification, surgery only is recommended even if incomplete. However, it is not known whether the genomic background of these tumors may influence outcome.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::43477caef538b2e27cbc66c986f93535
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13330
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13330
Autor:
Ambros, I.M., Tonini, G.P., Gross, N., Mosseri, V., Pötschger, U., Beiske, K., Berbegall, A.P., Bénard, J., Bown, N., Caron, H., Combaret, V., Couturier, J., Defferrari, R., Delattre, O., Jeison, M., Kogner, P., Lunec, J., Marques, B., Martinsson, T., Mazzocco, K., Noguera, R., Schleiermacher, G., Valent, A., Van Roy, N., Villamon, E., Janousek, D., Pribill, I., Glogova, E., Attiyeh, E.F., Hogarty, M.D., Monclair, T., Holmes, K., Valteau-Couanet, D., Pearson ADJ, A.D.J., Castel, V., Tweddle, D.A., Park, J.R., Cohn, S., Ladenstein, R., Beck-Popovic, M., De Bernardi, B., Michon, J., Ambros, P.F.
BACKGROUND: Biology based treatment reduction, i.e. surgery alone also in case of not totally resected tumors, was advised in neuroblastoma patients with localized resectable disease without MYCN amplification. However, whether the genomic background
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2016::66b18bf7b74b4a5d7ecf2168fe1bbcf4
https://hdl.handle.net/10400.18/5899
https://hdl.handle.net/10400.18/5899
Autor:
Schleiermacher, G, Defferrari, R, Mazzocco, K, Noguera, R, Varesio, L, Ambros, Im, Bernheim, A, Combaret, V, Jeison, M, van Roy, N, Michon, J, Mosseri, V, Bermudes, Jd, Canete, A, DI CATALDO, Andrea, Papadakis, V, Wheeler, K, Ambros, Pf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4731::f45043dd0aca548312fe79d1c7963075
http://hdl.handle.net/20.500.11769/107166
http://hdl.handle.net/20.500.11769/107166
Autor:
Schleiermacher, G, Michon, J, Ribeiro, A, Pierron, G, Mosseri, V, Rubie, H, Munzer, C, Bénard, J, Auger, N, Combaret, V, Janoueix Lerosey, I, Pearson, A, Tweddle, Da, Bown, N, Gerrard, M, Wheeler, K, Noguera, R, Villamon, E, Cañete, A, Castel, V, Marques, B, de Lacerda, A, Tonini, Gp, Mazzocco, K, Defferrari, R, de Bernardi, B, DI CATALDO, Andrea, van Roy, N, Brichard, B, Ladenstein, R, Ambros, I, Ambros, P, Beiske, K, Delattre, O, Couturier, J.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4731::61074b4a29b90f8814574499d95fcb8d
http://hdl.handle.net/20.500.11769/61832
http://hdl.handle.net/20.500.11769/61832
Autor:
Ponchel, F., Toomes, C., Bransfield, K., Leong, F.T., Douglas, S.H., Field, S.L., Bell, S.M., Combaret, V., Puisieux, A., Mighell, A.J., Robinson, P.A., Inglehearn, C.F., Isaacs, J.D., Markham, A.F.
BACKGROUND:\ud \ud Real-time PCR is increasingly being adopted for RNA quantification and genetic analysis. At present the most popular real-time PCR assay is based on the hybridisation of a dual-labelled probe to the PCR product, and the development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::4081a53394d74f615237e1102679e629
https://eprints.whiterose.ac.uk/39/1/1472-6750-3-18.pdf
https://eprints.whiterose.ac.uk/39/1/1472-6750-3-18.pdf
Publikováno v:
Europe PubMed Central
The prognosis of pediatric neuroblastoma depends both on clinical presentation and on certain cellular and molecular characteristics. At the present time, two hypotheses can be drawn to explain both clinical and biological heterogeneity. In the first
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f423652ce1a3e810894ab3cd80952ac9
https://pubmed.ncbi.nlm.nih.gov/9752317
https://pubmed.ncbi.nlm.nih.gov/9752317
Autor:
Favrot, M. C., Ambros, P., Schilling, F., Frappaz, D., Combaret, V., Berthold, F., Dominici, Carlo, Erttmann, R., Esteve, J., Jenkner, A., Kerbl, R., Mann, J., Mathieu, P., Parker, L., Powell, J., Philip, T.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 7(6)
The prognosis of pediatric neuroblastoma depends both on clinical presentation and on certain cellular and molecular characteristics. Screening programs have been initiated in infants of less than one year of age, based on the hypothesis that neurobl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::441396d1a54862171074b5530e68a6ae
https://pubmed.ncbi.nlm.nih.gov/8879375
https://pubmed.ncbi.nlm.nih.gov/8879375
Autor:
Defferrari, R, Mazzocco, K, Ambros, I M, Ambros, P F, Bedwell, C, Beiske, K, Bénard, J, Berbegall, A P, Bown, N, Combaret, V, Couturier, J, Erminio, G, Gambini, C, Garaventa, A, Gross, N, Haupt, R, Kohler, J, Jeison, M, Lunec, J, Marques, B
Publikováno v:
British Journal of Cancer; 1/20/2015, Vol. 112 Issue 2, p290-295, 6p, 1 Chart, 4 Graphs